|
1
|
Hu DN, Yu GP, McCormick SA, Schneider S
and Finger PT: Population-based incidence of uveal melanoma in
various races and ethnic groups. Am J Ophthalmol. 140:612–617.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Damato B and Heimann H: Personalized
treatment of uveal melanoma. Eye (Lond). 27:172–179. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu YC, Tsai CC, Lee FL, Lee SM and Kao
SC: Mortality from uveal melanoma treated by enucleation -a 16-year
survey in Taiwan. Acta Ophthalmol. 91:e583–e584. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shoushtari AN and Carvajal RD: Treatment
of uveal melanoma. Cancer Treat Res. 167:281–293. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang X, Tang N, Hadden T and Rishi A:
Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta.
1813:1978–1986. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang H, Quirion R, Little PJ, Cheng Y,
Feng ZP, Sun HS, Xu JP and Zheng WH: Forkhead box O transcription
factors as possible mediators in the development of major
depression. Neuropharmacology. 99:527–537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu H: Targeting forkhead box
transcription factors FOXM1 and FOXO in leukemia (Review). Oncol
Rep. 32:1327–1334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shukla S, Shukla M, MacLennan GT, Fu P and
Gupta S: Deregulation of FOXO3A during prostate cancer progression.
Int J Oncol. 34:1613–1620. 2009.PubMed/NCBI
|
|
9
|
Fonseca EAI, Oliveira MA, Eichler R,
Akamine EH, Carvalho MHC, Barbosa AM, Dekker RFH, Khaper N and
Fortes ZB: Antitumor effect of metformin in breast cancer is
associated with AMPK and FOXO3a activation. Cancer Res. 73:2013.
View Article : Google Scholar
|
|
10
|
Obsil T and Obsilova V: Structure/function
relationships underlying regulation of FOXO transcription factors.
Oncogene. 27:2263–2275. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vogt PK, Jiang H and Aoki M: Triple layer
control: Phosphorylation, acetylation and ubiquitination of FOXO
proteins. Cell Cycle. 4:908–913. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Zhou X, Huang J, Mu N, Guo Z, Wen
Q, Wang R, Chen S, Feng ZP and Zheng W: The role of Akt/FoxO3a in
the protective effect of venlafaxine against corticosterone-induced
cell death in PC12 cells. Psychopharmacology (Berl). 228:129–141.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Biggs WH, Meisenhelder J, Hunter T,
Cavenee WK and Arden KC: Protein kinase B/Akt-mediated
phosphorylation promotes nuclear exclusion of the winged helix
transcription factor FKHR1. P Natl Acad Sci USA. 96:7421–7426.
1999. View Article : Google Scholar
|
|
14
|
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo
P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt
promotes cell survival by phosphorylating and inhibiting a forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang ED, Nuñez G, Barr FG and Guan KL:
Negative regulation of the forkhead transcription factor FKHR by
Akt. J Biol Chem. 274:16741–16746. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui M, Huang Y, Zhao Y and Zheng J:
Transcription factor FOXO3a mediates apoptosis in HIV-1-infected
macrophages. J Immunol. 180:898–906. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan F, Liao R, Farhan M, Wang T, Chen J,
Wang Z, Little PJ and Zheng W: Elucidating the role of the FoxO3a
transcription factor in the IGF-1-induced migration and invasion of
uveal melanoma cancer cells. Biomed Pharmacother. 84:1538–1550.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Paik JH, Kollipara R, Chu G, Ji H, Xiao Y,
Ding Z, Miao L, Tothova Z, Horner JW, Carrasco DR, et al: FoxOs are
lineage-restricted redundant tumor suppressors and regulate
endothelial cell homeostasis. Cell. 128:309–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Burgering BM and Kops GJ: Cell cycle and
death control: Long live Forkheads. Trends Biochem Sci. 27:352–360.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ning Y, Luo C, Ren K, Quan M and Cao J:
FOXO3a-mediated suppression of the self-renewal capacity of
sphere-forming cells derived from the ovarian cancer SKOV3 cell
line by 7-difluoromethoxy1-5,4′-di-n-octyl genistein. Mol Med Rep.
9:1982–1988. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He LY, Wei X, Du L, Liu L, Xu F, Min J, Li
C, Tao DD, Chen Q, Hu JB and Gong JP: Remarkably reduced expression
of FoxO3a in metaplastic colorectum, primary colorectal cancer and
liver metastasis. J Huazhong Univ Sci Technolog Med Sci.
33:205–211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin CH, Chang CY, Lee KR, Lin HJ, Chen TH
and Wan L: Flavones inhibit breast cancer proliferation through the
Akt/FOXO3a signaling pathway. BMC Cancer. 15:9582015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang JY, Zong CS, Xia W, Yamaguchi H, Ding
Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC, et al: ERK promotes
tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation.
Nat Cell Biol. 10:138–148. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang WS, Dolloff NG and El-Deiry WS: ERK
and MDM2 prey on FOXO3a. Nat Cell Biol. 10:125–126. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang H, Zhang Q, Zhang L, Little PJ, Xie
X, Meng Q, Ren Y, Zhou L, Gao G, Quirion R and Zheng W:
Insulin-like growth factor-1 induces the phosphorylation of PRAS40
via the PI3K/Akt signaling pathway in PC12 cells. Neurosci Lett.
516:105–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang K, Moran A, Holst J and Wang Q:
PI3K/Akt signalling regulates leucine transport in prostate cancer.
Bju Int. 116:34–35. 2015.
|
|
28
|
Matsuzaki H, Daitoku H, Hatta M, Tanaka K
and Fukamizu A: Insulin-induced phosphorylation of FKHR (Foxo1)
targets to proteasomal degradation. Proc Natl Acad Sci USA. 100:pp.
11285–11290. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wen Q, Duan X, Liao R, Little P, Gao G,
Jiang H, Lalit S, Quirion R and Zheng W: Characterization of
intracellular translocation of Forkhead transcription factor O
(FoxO) members induced by NGF in PC12 cells. Neurosci Lett.
498:31–36. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View
Article : Google Scholar : PubMed/NCBI
|
